Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo

Biochemical and Biophysical Research Communications
Toyokazu SasakiHiroyuki Hamakawa

Abstract

The serine/threonine kinase Akt has three highly homologous isoforms in mammals: Akt1, Akt2, and Akt3. Recent studies indicate that Akt is often constitutively active in many types of human malignancy. Here we investigated the expression and function of Akt isoforms in human prostatic carcinoma cells. Initially, we used Western blotting to examine Akt expression in four human prostate cancer cell lines. Next, small-interfering RNAs (siRNAs) specific for Akt isoforms were used to elucidate their role on the in vitro and in vivo growth of prostate cancer cells. Expression of Akt1 and Akt2 was detected in all cells tested, but Akt3 was expressed only in cancer cells that did not express androgen receptors. All synthetic siRNAs against Akt isoforms suppressed their expression and inhibited the growth of cancer cells in vitro. Furthermore, atelocollagen-mediated systemic administration of siRNAs significantly reduced the growth of tumors that had been subcutaneously xenografted. These results suggest that targeting Akt isoforms could be an effective treatment for prostate cancers.

References

Aug 22, 1995·International Journal of Cancer. Journal International Du Cancer·A BellacosaJ R Testa
Apr 20, 1999·Biochemical and Biophysical Research Communications·K NakataniR A Roth
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
Feb 3, 2004·Journal of Cellular Biochemistry·Mary-Ellen Taplin, Steven P Balk
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Mar 22, 2008·Biochemical and Biophysical Research Communications·Shingo HaraHiroyuki Hamakawa
Aug 1, 2008·Endocrine-related Cancer·Meng-Lei Zhu, Natasha Kyprianou
Jul 15, 2009·Cell Cycle·Eva Gonzalez, Timothy E McGraw
Dec 17, 2009·Biochemical and Biophysical Research Communications·Koji AzumaHiroyuki Hamakawa

❮ Previous
Next ❯

Citations

Oct 28, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Shinichiro InabaYoshifumi Takei
May 27, 2014·Therapeutic Delivery·Ichiro Fujimoto, Yoshifumi Takei
Sep 1, 2015·International Journal of Oncology·Koh-Ichi NakashiroHiroyuki Hamakawa
Apr 17, 2012·Journal of Drug Delivery·Koji HanaiNorimasa Sawada
Nov 11, 2011·Cell Biology International·Oumou GoundiamMuriel Vayssade
Sep 21, 2011·The Prostate·Cécile Le PageAnne-Marie Mes-Masson
Jun 4, 2013·Biomaterials·Pauline ResnierCatherine Passirani
Dec 2, 2011·The Journal of Toxicological Sciences·Shingo OgawaIchiro Fujimoto
Oct 22, 2013·Cancer Letters·Borja Ballarín-GonzálezKenneth Alan Howard
Oct 25, 2016·International Journal of Pharmaceutics·Jia-Liang ZhangHu-Lin Jiang
Aug 10, 2013·Molecular & Cellular Proteomics : MCP·Demetris C IacovidesJoe W Gray
Jan 23, 2014·Circulation. Heart Failure·Yonathan F MelmanSaumya Das
Nov 26, 2015·Science Advances·Xin HanLidong Qin
Sep 15, 2020·Journal of Cellular and Molecular Medicine·Geetha NalairndranChee-Onn Leong
May 20, 2014·Cancer Discovery·Y Rebecca ChinAlex Toker
May 4, 2012·Cancer Research·Sharanjot SainiRajvir Dahiya

❮ Previous
Next ❯

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.